Advisory Board September 12, 2023
FDA approves new COVID-19 shots
The new monovalent shots, which were developed by Moderna and Pfizer-BioNTech, target the XBB.1.5 subvariant of omicron and were approved for everyone ages 6 months and older.
Health officials noted the vaccine is not a booster shot but actually an entirely new formula.
“The public can be assured that these updated vaccines have met the agency’s rigorous...